Quest Health Partners with Rimidi to Drive Measurable Improvements in Blood Glucose for Diabetes Patients Using Remote Patient Monitoring

Early data reveals 11% average blood glucose reduction and up to 1% A1C improvement for participating patients after just two months

ATLANTA – June 18, 2025 –  Quest Health Solutions, a national leader in diabetes care and medical device fulfillment, today announced compelling results from its Remote Patient Monitoring (RPM) program in partnership with Rimidi, a market-leading digital health company that supports healthcare providers with EHR-integrated software, services, and connected devices. In just two months, Quest Health RPM Services — powered by Rimidi — led to an 11% improvement in average blood glucose readings among participating patients.

Quest Health provides a full spectrum of direct-to-patient services to support diabetes and chronic condition management, including fulfillment of Continuous Glucose Monitors (CGMs), insurance verification and documentation support. Through its virtual clinic and remote patient monitoring program, Quest engages patients in real time using connected devices, while supporting providers by streamlining clinical workflows and driving better health outcomes.

“Rimidi makes RPM effortless. Our team and partners love the quick access to charting, billing, and patient info — all in one user-friendly platform,” said Jim Klauder, RD, CDCES, LDN, Head of Patient Care at Quest Health RPM Services.

With Rimidi’s platform integrated into Quest’s athenahealth EHR system, clinical staff can efficiently monitor and manage patients using both cellular-enabled Blood Glucose Monitors and CGMs. The platform enables risk stratification, customizable alerts, and robust documentation tools to support both clinical decision-making and billing.

In an early cohort of patients using connected Blood Glucose Monitors:

• Overall average glucose levels dropped by 11%, from 176 mg/dL to 157.5 mg/dL
  
• Morning glucose readings (5 a.m. to 9 a.m.) dropped by 16%, from 176 mg/dL to 147.9 mg/dL
  
• These improvements translated to an estimated A1C reduction of approximately 1% for morning readings and 0.7% for overall daily readings

“Remote monitoring — paired with the right clinical insights, in the right place, at the right time — empowers providers to better support patients in managing their diabetes, and these early results clearly reflect that,” said Rimidi CEO Lucienne Ide, MD, PhD. “We’re proud to work with Quest Health as they bring their excellence in diabetes care to RPM programs and broaden the reach and impact of their services.”

Quest Health plans to expand its RPM offerings to include support for patients using additional devices, such as blood pressure monitors and pulse oximeters, and to offer its RPM services to healthcare providers across the country. This initiative builds on Quest’s core offerings by complementing its best-in-class CGM and diabetes supply fulfillment.

To learn more about Quest Health Solutions, visit https://www.questhealthsolutions.com. To learn more about Rimidi’s comprehensive platform for Remote Patient Monitoring, visit https://rimidi.com/software/remote-patient-monitoring. 

About Rimidi
Created by doctors, for doctors, Rimidi is a digital health company that supports healthcare providers in the delivery of remote patient monitoring and chronic disease management with EHR-integrated software, services, and connected devices. By combining clinical data from the EHR with data from connected devices and patient surveys, Rimidi presents a complete picture of the patient and supports care delivery across the continuum from the clinic to the home to allow for proactive, guideline-based management and prioritization of highest-need patients. For more information, visit rimidi.com and follow us on X, formerly known as Twitter, and LinkedIn.

About Quest: 
Quest Health Solutions, a Vast Medical Holdings company, is a healthcare services and medical equipment provider focused on improving outcomes for individuals living with chronic conditions like diabetes. Through a combination of direct-to-patient support, remote physiologic monitoring (RPM), and home delivery of devices like continuous glucose monitors (CGMs), Quest helps patients better manage their health from home. Its expanding suite of virtual care solutions and remote care programs are designed to align with the needs of healthcare providers, payers, and manufacturers seeking scalable, patient-centric delivery models. To learn more, visit www.questhealthsolutions.com.

Media Contacts:

Emily Keough
Director of Marketing and Channel Partnerships
emily.keough@rimidi.com

Kendall Kosek
Alloy, on behalf of Rimidi
rimidi@alloycrew.com